Join
Live feed
·
INSIDERFilingvia Quantisnow
CERo Therapeutics Holdings Inc. logo

Director Laporte Kathleen converted options into 965,997 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CERO· CERo Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERO (CERo Therapeutics Holdings Inc.) and more on Quantisnow.